AI Terminal
Transgene
Regulatory Filings • Jan 6, 2022
1715_rns_2022-01-06_bef8ba89-d5c0-4743-a474-efe4abdf5dbf.pdf
Regulatory Filings
Open in ViewerOpens in native device viewer
PRESS RELEASE
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2021
Strasbourg, January 06, 2021 – 05:45 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2021, the following resources were managed through the liquidity account:
- 176,500 shares
- € 334,853.00
In the second half of 2021, a total of:
| Purchases | 434,514 shares |
€ 1,060,091 | 849 market transactions |
|---|---|---|---|
| Sales | 433,014 shares |
€ 1,082,327 | 902 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
Cash balance of the liquidity contract: € 500,000.00
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
- 164,183 shares
- € 246,158.00
Contacts
Transgene:
Jean-Philippe Del CFO +33 (0)3 88 27 91 00 [email protected]